欢迎来到范德生物BIOFOUNT
范德生物中国

中文范德生物中文语言

范德生物产品购买购物车
0
搜索
ON-013100_865783-95-5_产品详情
865783-95-5
  • names:

    ON-013100

  • CAS号:

    865783-95-5

    MDL Number:
  • MF(分子式): C19H22O7S MW(分子量): 394.44
  • EINECS: Reaxys Number:
  • Pubchem ID: Brand:BIOFOUNT
ON-013100
货品编码 规格 纯度 价格 (¥) 现价(¥) 特价(¥) 库存描述 数量 总计 (¥)
YZM002279-5mg 5mg 98.23% ¥ 2430.00 ¥ 2430.00 2-3天
- +
¥ 0.00
YZM002279-1mg 1mg 98.23% ¥ 1170.00 ¥ 1170.00 2-3天
- +
¥ 0.00
快速询价
收起
你想询价的产品
请准确填写您的联系方式,以便为您提供最好的服务。
中文别名
英文别名
CAS号 865783-95-5
Inchi
InchiKey
分子式 Formula C19H22O7S
分子量 Molecular Weight 394.44
溶解度Solubility
性状
储藏条件 Storage conditions 粉末Powder: -20°C 3 years年 4°C 2 years年 / In solvent溶液中:-80°C 6 months月 -20°C 1 month月
ON-013100(CAS:865783-95-5)实验注意事项:
1.实验前需戴好防护眼镜,穿戴防护服和口罩,佩戴手套,避免与皮肤接触。
2.实验过程中如遇到有毒或者刺激性物质及有害物质产生,必要时实验操作需要手套箱内完成以免对实验人员造成伤害
3.实验后产生的废弃物需分类存储,并交于专业生物废气物处理公司处理,以免造成环境污染Experimental considerations:
1. Wear protective glasses, protective clothing and masks, gloves, and avoid contact with the skin during the experiment.
2. The waste generated after the experiment needs to be stored separately, and handed over to a professional biological waste gas treatment company to avoid environmental pollution.
产品说明 ON-013100,一种抗肿瘤药物,作为有丝分裂的抑制剂,能够抑制细胞周期蛋白 D1(Cyclin D1)的表达
IntroductionON13100, an antineoplastic drug, acts a mitotic inhibitor that could inhibitCyclin D1expression.
Application1
Application2
Application3
ON-013100,一种抗肿瘤药物,作为有丝分裂的抑制剂,能够抑制细胞周期蛋白 D1(Cyclin D1)的表达。ON-013100, an antineoplastic drug, acts a mitotic inhibitor that could inhibitCyclin D1expression.
警示图
危险性
危险性警示
安全声明
安全防护
备注
【1】.Cho SY, et al. Determination of the glucuronide metabolite of ON 013100, a benzylstyrylsulfone antineoplastic drug, in colon cancer cells using LC/MS/MS. J Pharm Biomed Anal. 2013 Mar 5;75:138-44.
【2】.Park IW, et al. Evaluation of novel cell cycle inhibitors in mantle cell lymphoma. Oncogene. 2007 Aug 16;26(38):5635-42.
【3】.Neel Jasani, et al. Potent anticancer activity of an orally bioavailable small molecule, ON 013100, and its water soluble derivative, briciclib, a clinical-stage eIF4E-targeted agent. AACR 106th Annual Meeting 2015; April 18-22, 2015; Philadelphia, PA.
    对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
        新闻
        抱歉,暂无数据!
        My title page contents